Not applicableStudy completedNCT05950308
What this trial is testing
Assessment of Immune Response in Multiple Sclerosis Patients With COVID-19/Vaccination Treated With Ofatumumab and Other Disease Modifying Therapies
Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 61